BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19859844)

  • 1. Cell cycle inhibition and apoptosis induced by curcumin in Ewing sarcoma cell line SK-NEP-1.
    Singh M; Pandey A; Karikari CA; Singh G; Rakheja D
    Med Oncol; 2010 Dec; 27(4):1096-101. PubMed ID: 19859844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor I receptor pathway inhibition by ADW742, alone or in combination with imatinib, doxorubicin, or vincristine, is a novel therapeutic approach in Ewing tumor.
    Martins AS; Mackintosh C; Martín DH; Campos M; Hernández T; Ordóñez JL; de Alava E
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3532-40. PubMed ID: 16740780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin induces cell cycle arrest and apoptosis in human osteosarcoma (HOS) cells.
    Lee DS; Lee MK; Kim JH
    Anticancer Res; 2009 Dec; 29(12):5039-44. PubMed ID: 20044614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arsenic trioxide potentiates the effectiveness of etoposide in Ewing sarcomas.
    Boehme KA; Nitsch J; Riester R; Handgretinger R; Schleicher SB; Kluba T; Traub F
    Int J Oncol; 2016 Nov; 49(5):2135-2146. PubMed ID: 27665785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IGF-1R/MDM2 relationship confers enhanced sensitivity to RITA in Ewing sarcoma cells.
    Di Conza G; Buttarelli M; Monti O; Pellegrino M; Mancini F; Pontecorvi A; Scotlandi K; Moretti F
    Mol Cancer Ther; 2012 Jun; 11(6):1247-56. PubMed ID: 22461661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma.
    Hensel T; Giorgi C; Schmidt O; Calzada-Wack J; Neff F; Buch T; Niggli FK; Schäfer BW; Burdach S; Richter GH
    Oncotarget; 2016 Jan; 7(2):1451-63. PubMed ID: 26623725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple Active Compounds from Viscum album L. Synergistically Converge to Promote Apoptosis in Ewing Sarcoma.
    Twardziok M; Kleinsimon S; Rolff J; Jäger S; Eggert A; Seifert G; Delebinski CI
    PLoS One; 2016; 11(9):e0159749. PubMed ID: 27589063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimisation of pyrazolo[1,5-a]pyrimidin-7(4H)-one derivatives as novel Hsp90 C-terminal domain inhibitors against Ewing sarcoma.
    Zajec Ž; Dernovšek J; Distel M; Gobec M; Tomašič T
    Bioorg Chem; 2023 Feb; 131():106311. PubMed ID: 36495678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imatinib revives the therapeutic potential of metformin on ewing sarcoma by attenuating tumor hypoxic response and inhibiting convergent signaling pathways.
    Nan X; Wang J; Cheng H; Yin Z; Sheng J; Qiu B; Lau CC; Yustein JT; Zhao H; Wong STC
    Cancer Lett; 2020 Jan; 469():195-206. PubMed ID: 31672491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the epigenetic readers in Ewing sarcoma inhibits the oncogenic transcription factor EWS/Fli1.
    Jacques C; Lamoureux F; Baud'huin M; Rodriguez Calleja L; Quillard T; Amiaud J; Tirode F; Rédini F; Bradner JE; Heymann D; Ory B
    Oncotarget; 2016 Apr; 7(17):24125-40. PubMed ID: 27006472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BET bromodomain inhibitors suppress EWS-FLI1-dependent transcription and the IGF1 autocrine mechanism in Ewing sarcoma.
    Loganathan SN; Tang N; Fleming JT; Ma Y; Guo Y; Borinstein SC; Chiang C; Wang J
    Oncotarget; 2016 Jul; 7(28):43504-43517. PubMed ID: 27259270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. XI-006 induces potent p53-independent apoptosis in Ewing sarcoma.
    Pishas KI; Adwal A; Neuhaus SJ; Clayer MT; Farshid G; Staudacher AH; Callen DF
    Sci Rep; 2015 Jun; 5():11465. PubMed ID: 26095524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic induction of apoptosis by a polo-like kinase 1 inhibitor and microtubule-interfering drugs in Ewing sarcoma cells.
    Weiß LM; Hugle M; Romero S; Fulda S
    Int J Cancer; 2016 Jan; 138(2):497-506. PubMed ID: 26260582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the IGF1R/PI3K/AKT Pathway Sensitizes Ewing Sarcoma to BET Bromodomain Inhibitors.
    Loganathan SN; Tang N; Holler AE; Wang N; Wang J
    Mol Cancer Ther; 2019 May; 18(5):929-936. PubMed ID: 30926641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clotam enhances anti-proliferative effect of vincristine in Ewing sarcoma cells.
    Shelake S; Sankpal UT; Eslin D; Bowman WP; Simecka JW; Raut S; Ray A; Basha R
    Apoptosis; 2019 Feb; 24(1-2):21-32. PubMed ID: 30610505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imatinib inhibits proliferation of Ewing tumor cells mediated by the stem cell factor/KIT receptor pathway, and sensitizes cells to vincristine and doxorubicin-induced apoptosis.
    González I; Andreu EJ; Panizo A; Inogés S; Fontalba A; Fernández-Luna JL; Gaboli M; Sierrasesúmaga L; Martín-Algarra S; Pardo J; Prósper F; de Alava E
    Clin Cancer Res; 2004 Jan; 10(2):751-61. PubMed ID: 14760098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ML327 induces apoptosis and sensitizes Ewing sarcoma cells to TNF-related apoptosis-inducing ligand.
    Rellinger EJ; Padmanabhan C; Qiao J; Appert A; Waterson AG; Lindsley CW; Beauchamp RD; Chung DH
    Biochem Biophys Res Commun; 2017 Sep; 491(2):463-468. PubMed ID: 28716733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways augment the sensitivity to actinomycin D in Ewing sarcoma.
    Yamamoto T; Ohno T; Wakahara K; Nagano A; Kawai G; Saitou M; Takigami I; Matsuhashi A; Yamada K; Shimizu K
    J Cancer Res Clin Oncol; 2009 Aug; 135(8):1125-36. PubMed ID: 19205734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzochloroporphyrin derivative photosensitizer-mediated photodynamic therapy for Ewing sarcoma.
    Sun M; Zhou C; Zeng H; Yin F; Wang Z; Yao J; Hua Y; Cai Z
    J Photochem Photobiol B; 2016 Jul; 160():178-84. PubMed ID: 27113445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin-mediated regulation of Notch1/hairy and enhancer of split-1/survivin: molecular targeting in cholangiocarcinoma.
    Koprowski S; Sokolowski K; Kunnimalaiyaan S; Gamblin TC; Kunnimalaiyaan M
    J Surg Res; 2015 Oct; 198(2):434-40. PubMed ID: 25890434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.